Red White & Bloom Brands Files 2025-Q3 Interim Financial Statements

Stock Information for BriaCell Therapeutics Corp.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About BriaCell Therapeutics Corp.

Red White & Bloom Brands' Subsidiary, Emblem Cannabis Corporation, Completes Acquisition of Ayurcann's Health Canada-Licensed Manufacturing Operations, Leading Vape & Pre-Roll Brands, and Expanded National Distribution Capabilities
Red White & Bloom Brands' Subsidiary, Emblem Cannabis Corporation, Assumes Debtor-In-Possession Financing for Ayurcann Following Assignment From Auxly Cannabis Group
Red White & Bloom Brands' Subsidiary, Emblem Cannabis, Selected as Successful Bidder to Acquire Health Canada-Licensed Manufacturing Operations, Leading Vape & Pre-Roll Brands, and Expanded National Distribution Capabilities
Red White & Bloom Brands Announces Appointment of Michael Di Brina as New Director
Red White & Bloom Brands Closes Debt Settlement
CSE Bulletin: Reinstatement - Red White & Bloom Brands Inc. (RWB)
Canadian Investment Regulatory Organization Trade Resumption - RWB
Red White & Bloom Files 2025 Interim Financial Statements

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.